Antibiotic Resistance Patterns of Helicobacter pylori in Africa

Autor/innen

  • Amlsha Kahsay
  • Rezene Abraha
  • Yemane Weldu

Schlagwörter:

H. pylori, Antibiotics, resistance, Africa

Abstract

To eradicate Helicobacter pylori (H. pylori), antibiotic therapy must be adapted to the local resistance patterns. However, the epidemiology of drug resistance pattern of H. pylori is poorly documented in Africa. Therefore, the present review is aimed to review the prevalence of antibiotic resistant H. pylori from previous studies in Africa. A computerized English language literature search of PubMed, MEDLINE and Google Scholar was performed in January 2016. Only 11 articles met the inclusion criteria. The average H. pylori antibiotic resistance was 79.66% for metronidazole, 41.03% for clarithromycin, 42.3% for amoxicillin, 63.19% for tetracycline, 30.16 for erythromycin, and 3.9% for ciprofloxacin. No resistance was documented for clindamycin. H. pylori antibiotic resistance has been on rise in the last 10 years even if clindamycin and ciprofloxacin seems to be effective drugs. Therefore, empirical therapy for H. pylori must be based on current information on antimicrobial resistance patterns of the bacteria.Keywords: H. pylori, antibiotics, resistance, Africa

Autor/innen-Biografien

  • Amlsha Kahsay
    Department of Medical Microbiology and Immunology, Institute of Biomedical Sciences, College of Health Sciences, Mekelle University, Ethiopia 
  • Rezene Abraha
    Department of Biochemistry, Institute of Biomedical Sciences, College of Health Sciences, Mekelle University, Ethiopia
  • Yemane Weldu
    Department of Medical Microbiology and Immunology, Institute of Biomedical Sciences, College of Health Sciences, Mekelle University, Ethiopia 

Downloads

Veröffentlicht

2017-04-28

Ausgabe

Bd. 7 Nr. 1 (2017)

Rubrik

Review Articles

Lizenz

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.